Cytokinetics, Incorporated
US ˙ NasdaqGS ˙ US23282W6057

Introduktion

Denne side giver en omfattende analyse af den kendte insiderhandelshistorie for Sandford D Smith. Insidere er embedsmænd, direktører eller betydelige investorer i en virksomhed. Det er ulovligt for insidere at foretage handler i deres virksomheder baseret på specifik, ikke-offentlig information. Dette betyder ikke, at det er ulovligt for dem at handle i deres egne virksomheder. De skal dog rapportere alle handler til SEC via en formular 4. På trods af disse begrænsninger tyder akademisk forskning på, at insidere - generelt - har en tendens til at klare sig bedre end markedet i deres egne virksomheder.

Gennemsnitlig handelsrentabilitet

Den gennemsnitlige handelsrentabilitet er det gennemsnitlige afkast af alle køb på det åbne marked foretaget af insideren i de sidste tre år. For at beregne dette undersøger vi ethvert åbent marked, uplanlagte køb foretaget af insideren, eksklusive alle handler, der var markeret som en del af en 10b5-1-handelsplan. Vi beregner derefter den gennemsnitlige præstation for disse handler over 3, 6 og 12 måneder, idet vi tager et gennemsnit af hver af disse varigheder for at generere en endelig præstationsmåling for hver handel. Endelig tager vi et gennemsnit af alle præstationsmålingerne for at beregne en præstationsmåling for insideren. Denne liste inkluderer kun insidere, der har foretaget mindst tre handler i de sidste to år.

Hvis denne insiderhandelsrentabilitet er "N/A", så har insideren enten ikke foretaget nogen køb på det åbne marked i de sidste tre år, eller de handler, de har foretaget, er for nye til at beregne en pålidelig præstationsmåling.

Opdateringsfrekvens: Dagligt

Se listen over de mest profitable insiderhandlere.

Virksomheder med rapporterede insider-stillinger

SEC-registreringen viser, at Sandford D Smith har rapporteret besiddelser eller handler i følgende virksomheder:

Sikkerhed Titel Senest indberettede beholdninger
US:CYTK / Cytokinetics, Incorporated Director 18.801
Director 0
US:CUR / Neuralstem, Inc. Director 219.916
US:APRI / Apricus Biosciences, Inc. Director 35.000
US:NVLN / NOVELION THERAPEUTICS INC. Director 1.048
US:AEGR / Aegerion Pharmaceuticals, Inc. Director 0
Sådan fortolkes diagrammerne

Følgende diagrammer viser aktieudviklingen for værdipapirer efter hver åben-marked, ikke-planlagt handel foretaget af Sandford D Smith. Ikke-planlagt handel er handler, der ikke blev foretaget som en del af en 10b5-1-handelsplan. Aktieudviklingen er kortlagt som den kumulative procentvise ændring i aktiekursen. For eksempel, hvis en insiderhandel blev foretaget den 1. januar 2019, vil diagrammet vise den daglige procentvise ændring af værdipapiret til i dag. Hvis aktiekursen skulle gå fra $10 til $15 i løbet af denne tid, ville den kumulative procentvise ændring i aktiekursen være 50%. En prisændring fra 10 USD til 20 USD ville være 100 %, og en ændring i prisen på 10 USD til 5 USD ville være -50 %.

I sidste ende forsøger vi at bestemme, hvor tæt insiderens handler korrelerer med merafkast (positive eller negative) i aktiekursen for at se, om insideren timing deres handler til at drage fordel af insiderinformation. Overvej situationen, hvor en insider gjorde dette. I denne situation ville vi forvente enten (a) positive afkast efter køb eller (b) negative afkast efter salg. I tilfælde af (a) vil KØB-diagrammet vise en række opadskrånende kurver, der indikerer positive afkast efter hver købstransaktion. I tilfælde af (b) vil SALE-diagrammet vise en række nedadgående kurver, der indikerer negative afkast efter hver salgstransaktion.

Dette alene er dog ikke nok til at drage konklusioner. Hvis for eksempel aktiekursen i selskabet var i en ikke-cyklisk stigning over mange år, så ville vi forvente, at alle efterkøbsgrundene var opadgående. Ligeledes ville ikke-cykliske fald over mange år resultere i nedadgående post-trade plots. Ingen af disse diagrammer tyder på insiderhandel.

Den stærkeste indikator ville være en situation, hvor aktiekursen var ekstremt cyklisk, og der var både positive signaler i KØB-diagrammet og negative plots på SALG-diagrammet. Denne situation ville i høj grad tyde på en insider, der havde timing af handler til deres økonomiske fordel.

Insiderkøb CYTK / Cytokinetics, Incorporated – kortsigtet profitanalyse

I dette afsnit analyserer vi rentabiliteten af ethvert uplanlagt insiderkøb i åbent marked foretaget i CYTK / Cytokinetics, Incorporated. Denne analyse hjælper med at forstå, om insideren konsekvent genererer unormale afkast og er værd at følge. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste køb på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Maks
Pris kl
Maks
Maks
Fortjeneste ($)
Maks. afkast (%)
Der er ingen kendte uplanlagte åbne markedshandler for denne insider- og sikkerhedskombination

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

CYTK / Cytokinetics, Incorporated Insider Trades
Insidersalg CYTK / Cytokinetics, Incorporated – kortsigtet tabsanalyse

I dette afsnit analyserer vi den kortsigtede undgåelse af tab af ethvert uplanlagt insidersalg på åbent marked, der foretages i CYTK / Cytokinetics, Incorporated. Et konsekvent mønster af tabsforebyggelse kan tyde på, at fremtidige salgstransaktioner kan forudsige prisfald. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste salg på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Min
Pris kl
Min
Max tab
Undgået ($)
Max tab
Undgået (%)
2022-09-02 CYTK SMITH SANDFORD D 11.369 53,9700 11.369 53,9700 613.585 102 0.0000 -613.584 -100,00
2021-12-27 CYTK SMITH SANDFORD D 4.166 45,7900 4.166 45,7900 190.761
2021-12-27 CYTK SMITH SANDFORD D 20.000 45,7900 20.000 45,7900 915.800
2021-12-27 CYTK SMITH SANDFORD D 4.124 45,7900 4.124 45,7900 188.838
2021-11-19 CYTK SMITH SANDFORD D 5.000 41,2054 5.000 41,2054 206.027
2021-11-19 CYTK SMITH SANDFORD D 20.000 41,2054 20.000 41,2054 824.108
2021-11-19 CYTK SMITH SANDFORD D 4.032 41,2054 4.032 41,2054 166.140
2020-06-22 CYTK SMITH SANDFORD D 5.000 25,0000 5.000 25,0000 125.000
2020-06-22 CYTK SMITH SANDFORD D 5.000 24,0000 5.000 24,0000 120.000
2020-06-17 CYTK SMITH SANDFORD D 4.166 23,0000 4.166 23,0000 95.818
2020-06-17 CYTK SMITH SANDFORD D 2.741 23,0000 2.741 23,0000 63.043
2020-06-15 CYTK SMITH SANDFORD D 6.666 22,0000 6.666 22,0000 146.652
2020-06-12 CYTK SMITH SANDFORD D 10.879 20,7744 10.879 20,7744 226.005
2020-06-12 CYTK SMITH SANDFORD D 4.166 21,1000 4.166 21,1000 87.903

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

CYTK / Cytokinetics, Incorporated Insider Trades
Insiderkøb PALI / Palisade Bio, Inc. – kortsigtet profitanalyse

I dette afsnit analyserer vi rentabiliteten af ethvert uplanlagt insiderkøb i åbent marked foretaget i CYTK / Cytokinetics, Incorporated. Denne analyse hjælper med at forstå, om insideren konsekvent genererer unormale afkast og er værd at følge. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste køb på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Maks
Pris kl
Maks
Maks
Fortjeneste ($)
Maks. afkast (%)
Der er ingen kendte uplanlagte åbne markedshandler for denne insider- og sikkerhedskombination

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

PALI / Palisade Bio, Inc. Insider Trades
Insidersalg PALI / Palisade Bio, Inc. – kortsigtet tabsanalyse

I dette afsnit analyserer vi den kortsigtede undgåelse af tab af ethvert uplanlagt insidersalg på åbent marked, der foretages i CYTK / Cytokinetics, Incorporated. Et konsekvent mønster af tabsforebyggelse kan tyde på, at fremtidige salgstransaktioner kan forudsige prisfald. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste salg på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Min
Pris kl
Min
Max tab
Undgået ($)
Max tab
Undgået (%)
Der er ingen kendte uplanlagte åbne markedshandler for denne insider- og sikkerhedskombination

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

PALI / Palisade Bio, Inc. Insider Trades
Insiderkøb QLTI / The 2023 ETF Series Trust II - GMO International Quality ETF – kortsigtet profitanalyse

I dette afsnit analyserer vi rentabiliteten af ethvert uplanlagt insiderkøb i åbent marked foretaget i CYTK / Cytokinetics, Incorporated. Denne analyse hjælper med at forstå, om insideren konsekvent genererer unormale afkast og er værd at følge. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste køb på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Maks
Pris kl
Maks
Maks
Fortjeneste ($)
Maks. afkast (%)
Der er ingen kendte uplanlagte åbne markedshandler for denne insider- og sikkerhedskombination

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

QLTI / The 2023 ETF Series Trust II - GMO International Quality ETF Insider Trades
Insidersalg QLTI / The 2023 ETF Series Trust II - GMO International Quality ETF – kortsigtet tabsanalyse

I dette afsnit analyserer vi den kortsigtede undgåelse af tab af ethvert uplanlagt insidersalg på åbent marked, der foretages i CYTK / Cytokinetics, Incorporated. Et konsekvent mønster af tabsforebyggelse kan tyde på, at fremtidige salgstransaktioner kan forudsige prisfald. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste salg på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Min
Pris kl
Min
Max tab
Undgået ($)
Max tab
Undgået (%)
Der er ingen kendte uplanlagte åbne markedshandler for denne insider- og sikkerhedskombination

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

QLTI / The 2023 ETF Series Trust II - GMO International Quality ETF Insider Trades
Insiderkøb SEELQ / Seelos Therapeutics, Inc. – kortsigtet profitanalyse

I dette afsnit analyserer vi rentabiliteten af ethvert uplanlagt insiderkøb i åbent marked foretaget i CYTK / Cytokinetics, Incorporated. Denne analyse hjælper med at forstå, om insideren konsekvent genererer unormale afkast og er værd at følge. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste køb på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Maks
Pris kl
Maks
Maks
Fortjeneste ($)
Maks. afkast (%)
2014-10-23 APRI SMITH SANDFORD D 18.200 1,5933 18.200 1,5933 28.998 731
2014-10-22 APRI SMITH SANDFORD D 8.300 1,5242 8.300 1,5242 12.651

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

SEELQ / Seelos Therapeutics, Inc. Insider Trades
Insidersalg SEELQ / Seelos Therapeutics, Inc. – kortsigtet tabsanalyse

I dette afsnit analyserer vi den kortsigtede undgåelse af tab af ethvert uplanlagt insidersalg på åbent marked, der foretages i CYTK / Cytokinetics, Incorporated. Et konsekvent mønster af tabsforebyggelse kan tyde på, at fremtidige salgstransaktioner kan forudsige prisfald. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste salg på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Min
Pris kl
Min
Max tab
Undgået ($)
Max tab
Undgået (%)
Der er ingen kendte uplanlagte åbne markedshandler for denne insider- og sikkerhedskombination

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

SEELQ / Seelos Therapeutics, Inc. Insider Trades
Insiderhandelshistorie

Denne tabel viser den komplette liste over insiderhandler foretaget af Sandford D Smith som oplyst til Securities Exchange Commission (SEC).

Fil dato Transdato Form Ticker Sikkerhed Kode 10b5-1 Aktier Resterende aktier Procent
Lave om
Del
Pris
Tran
Værdi
Tilbage
Værdi
2024-01-03 2024-01-02 4 CYTK CYTOKINETICS INC
Common Stock
A - Award 148 18.801 0,79 84,12 12.450 1.581.540
2023-10-03 2023-10-02 4 CYTK CYTOKINETICS INC
Common Stock
A - Award 448 18.653 2,46 27,88 12.490 520.046
2023-07-05 2023-07-03 4 CYTK CYTOKINETICS INC
Common Stock
A - Award 374 18.205 2,10 33,36 12.477 607.319
2023-05-18 2023-05-10 4 CYTK CYTOKINETICS INC
Common Stock
A - Award 5.000 17.831 38,97
2023-04-05 2023-04-03 4 CYTK CYTOKINETICS INC
Common Stock
A - Award 298 12.831 2,38 37,71 11.238 483.857
2023-01-04 2023-01-03 4 CYTK CYTOKINETICS INC
Common Stock
A - Award 253 12.533 2,06 44,35 11.221 555.839
2022-10-05 2022-10-03 4 CYTK CYTOKINETICS INC
Common Stock
A - Award 110 12.280 0,90 51,11 5.622 627.631
2022-09-02 2022-09-02 4 CYTK CYTOKINETICS INC
Common Stock
S - Sale -11.369 12.170 -48,30 53,97 -613.585 656.815
2022-09-02 2022-09-02 4 CYTK CYTOKINETICS INC
Common Stock
M - Exercise 2.500 23.539 11,88 37,89 94.725 891.893
2022-09-02 2022-09-02 4 CYTK CYTOKINETICS INC
Common Stock
M - Exercise 5.834 21.039 38,37 24,32 141.883 511.668
2022-09-02 2022-09-02 4 CYTK CYTOKINETICS INC
Common Stock
M - Exercise 3.035 15.205 24,94 10,68 32.414 162.389
2022-07-12 2022-07-01 4 CYTK CYTOKINETICS INC
Common Stock
A - Award 137 12.170 1,14 41,00 5.617 498.970
2022-05-11 2022-05-10 4 CYTK CYTOKINETICS INC
Non-Qualified Stock Option (right to buy)
A - Award 10.000 10.000
2022-05-11 2022-05-10 4 CYTK CYTOKINETICS INC
Common Stock
A - Award 5.000 12.033 71,09
2022-04-01 2022-04-01 4 CYTK CYTOKINETICS INC
Common Stock
A - Award 146 7.033 2,12 38,38 5.603 269.927
2022-01-04 2022-01-03 4 CYTK CYTOKINETICS INC
Common Stock
A - Award 122 6.887 1,80 46,00 5.612 316.802
2021-12-28 2021-12-27 4 CYTK CYTOKINETICS INC
Non-Qualified Stock Option (right to buy)
M - Exercise -4.166 5.834 -41,66
2021-12-28 2021-12-27 4 CYTK CYTOKINETICS INC
Non-Qualified Stock Option (right to buy)
M - Exercise -20.000 0 -100,00
2021-12-28 2021-12-27 4 CYTK CYTOKINETICS INC
Non-Qualified Stock Option (right to buy)
M - Exercise -4.124 0 -100,00
2021-12-28 2021-12-27 4 CYTK CYTOKINETICS INC
Common Stock
S - Sale -4.124 6.765 -37,87 45,79 -188.838 309.769
2021-12-28 2021-12-27 4 CYTK CYTOKINETICS INC
Common Stock
M - Exercise 4.124 10.889 60,96 15,43 63.633 168.017
2021-12-28 2021-12-27 4 CYTK CYTOKINETICS INC
Common Stock
S - Sale -20.000 6.765 -74,72 45,79 -915.800 309.769
2021-12-28 2021-12-27 4 CYTK CYTOKINETICS INC
Common Stock
M - Exercise 20.000 26.765 295,64 21,61 432.200 578.392
2021-12-28 2021-12-27 4 CYTK CYTOKINETICS INC
Common Stock
S - Sale -4.166 6.765 -38,11 45,79 -190.761 309.769
2021-12-28 2021-12-27 4 CYTK CYTOKINETICS INC
Common Stock
M - Exercise 4.166 10.931 61,58 24,32 101.317 265.842
2021-11-19 2021-11-19 4 CYTK CYTOKINETICS INC
Non-Qualified Stock Option (right to buy)
M - Exercise -20.000 0 -100,00
2021-11-19 2021-11-19 4 CYTK CYTOKINETICS INC
Non-Qualified Stock Option (right to buy)
M - Exercise -4.032 0 -100,00
2021-11-19 2021-11-19 4 CYTK CYTOKINETICS INC
Non-Qualified Stock Option (right to buy)
M - Exercise -5.000 0 -100,00
2021-11-19 2021-11-19 4 CYTK CYTOKINETICS INC
Common Stock
S - Sale -4.032 6.765 -37,34 41,21 -166.140 278.755
2021-11-19 2021-11-19 4 CYTK CYTOKINETICS INC
Common Stock
M - Exercise 4.032 10.797 59,60 12,40 49.997 133.883
2021-11-19 2021-11-19 4 CYTK CYTOKINETICS INC
Common Stock
S - Sale -20.000 6.765 -74,72 41,21 -824.108 278.755
2021-11-19 2021-11-19 4 CYTK CYTOKINETICS INC
Common Stock
M - Exercise 20.000 26.765 295,64 14,25 285.000 381.401
2021-11-19 2021-11-19 4 CYTK CYTOKINETICS INC
Common Stock
S - Sale -5.000 6.765 -42,50 41,21 -206.027 278.755
2021-11-19 2021-11-19 4 CYTK CYTOKINETICS INC
Common Stock
M - Exercise 5.000 11.765 73,91 9,45 47.250 111.179
2021-10-04 2021-10-01 4 CYTK CYTOKINETICS INC
Common Stock
A - Award 306 6.765 4,74 36,74 11.242 248.546
2021-07-21 2021-07-19 4 CYTK CYTOKINETICS INC
Non-Qualified Stock Option (right to buy)
M - Exercise X -5.000 3.035 -62,23
2021-07-21 2021-07-19 4 CYTK CYTOKINETICS INC
Non-Qualified Stock Option (right to buy)
M - Exercise X -5.000 3.035 -62,23
2021-07-21 2021-07-19 4 CYTK CYTOKINETICS INC
Non-Qualified Stock Option (right to buy)
M - Exercise X -1.965 8.035 -19,65
2021-07-21 2021-07-19 4 CYTK CYTOKINETICS INC
Common Stock
S - Sale X -5.000 6.459 -43,63 28,50 -142.500 184.082
2021-07-21 2021-07-19 4 CYTK CYTOKINETICS INC
Common Stock
M - Exercise X 5.000 11.459 77,41 10,68 53.400 122.382
2021-07-21 2021-07-19 4 CYTK CYTOKINETICS INC
Common Stock
M - Exercise X 5.000 11.459 77,41 10,68 53.400 122.382
2021-07-21 2021-07-19 4 CYTK CYTOKINETICS INC
Common Stock
S - Sale X -1.965 6.459 -23,33 29,50 -57.968 190.540
2021-07-21 2021-07-19 4 CYTK CYTOKINETICS INC
Common Stock
M - Exercise X 1.965 8.424 30,42 10,68 20.986 89.968
2021-07-21 2021-07-19 4 CYTK CYTOKINETICS INC
Common Stock
S - Sale X -5.000 6.459 -43,63 29,00 -145.000 187.311
2021-07-08 2021-07-07 4 CYTK CYTOKINETICS INC
Common Stock
A - Award 63 6.459 0,98 19,77 1.246 127.694
2021-07-02 2021-07-01 4 CYTK CYTOKINETICS INC
Common Stock
A - Award 476 6.396 8,04 20,98 9.986 134.188
2021-05-13 2021-05-12 4 CYTK CYTOKINETICS INC
Non-Qualified Stock Option (right to buy)
A - Award 10.000 10.000
2021-05-13 2021-05-12 4 CYTK CYTOKINETICS INC
Common Stock
A - Award 5.000 5.920 543,48
2021-04-27 2021-04-26 4 CYTK CYTOKINETICS INC
Non-Qualified Stock Option (right to buy)
M - Exercise X -5.000 5.000 -50,00
2021-04-27 2021-04-26 4 CYTK CYTOKINETICS INC
Common Stock
S - Sale X -5.000 920 -84,46 27,00 -135.000 24.840
2021-04-27 2021-04-26 4 CYTK CYTOKINETICS INC
Common Stock
M - Exercise X 5.000 5.920 543,48 9,45 47.250 55.944
2021-04-27 2021-04-27 4 CYTK CYTOKINETICS INC
Non-Qualified Stock Option (right to buy)
M - Exercise X -5.000 15.000 -25,00
2021-04-27 2021-04-27 4 CYTK CYTOKINETICS INC
Non-Qualified Stock Option (right to buy)
M - Exercise X -4.739 0 -100,00
2021-04-27 2021-04-27 4 CYTK CYTOKINETICS INC
Common Stock
S - Sale X -5.000 920 -84,46 28,00 -140.000 25.760
2021-04-27 2021-04-27 4 CYTK CYTOKINETICS INC
Common Stock
M - Exercise X 5.000 5.920 543,48 10,68 53.400 63.226
2021-04-27 2021-04-27 4 CYTK CYTOKINETICS INC
Common Stock
S - Sale X -4.739 920 -83,74 27,50 -130.322 25.300
2021-04-27 2021-04-27 4 CYTK CYTOKINETICS INC
Common Stock
M - Exercise X 4.739 5.659 515,11 10,55 49.996 59.702
2021-04-23 2021-04-23 4 CYTK CYTOKINETICS INC
Non-Qualified Stock Option (right to buy)
M - Exercise X -5.000 10.000 -33,33
2021-04-23 2021-04-23 4 CYTK CYTOKINETICS INC
Common Stock
S - Sale X -5.000 920 -84,46 26,50 -132.500 24.380
2021-04-23 2021-04-23 4 CYTK CYTOKINETICS INC
Common Stock
M - Exercise X 5.000 5.920 543,48 9,45 47.250 55.944
2021-04-15 2021-04-15 4 CYTK CYTOKINETICS INC
Non-Qualified Stock Option (right to buy)
M - Exercise X -5.000 15.000 -25,00
2021-04-15 2021-04-15 4 CYTK CYTOKINETICS INC
Non-Qualified Stock Option (right to buy)
M - Exercise X -5.714 0 -100,00
2021-04-15 2021-04-15 4 CYTK CYTOKINETICS INC
Common Stock
S - Sale X -5.714 920 -86,13 25,00 -142.850 23.000
2021-04-15 2021-04-15 4 CYTK CYTOKINETICS INC
Common Stock
M - Exercise X 5.714 6.634 621,09 8,75 49.998 58.048
2021-04-15 2021-04-15 4 CYTK CYTOKINETICS INC
Common Stock
S - Sale X -5.000 920 -84,46 25,50 -127.500 23.460
2021-04-15 2021-04-15 4 CYTK CYTOKINETICS INC
Common Stock
M - Exercise X 5.000 5.920 543,48 9,45 47.250 55.944
2021-04-12 2021-04-09 4 CYTK CYTOKINETICS INC
Non-Qualified Stock Option (right to buy)
M - Exercise X -4.375 0 -100,00
2021-04-12 2021-04-09 4 CYTK CYTOKINETICS INC
Non-Qualified Stock Option (right to buy)
M - Exercise X -5.000 0 -100,00
2021-04-12 2021-04-09 4 CYTK CYTOKINETICS INC
Non-Qualified Stock Option (right to buy)
M - Exercise X -5.000 0 -100,00
2021-04-12 2021-04-09 4 CYTK CYTOKINETICS INC
Non-Qualified Stock Option (right to buy)
M - Exercise X -5.000 5.000 -50,00
2021-04-12 2021-04-09 4 CYTK CYTOKINETICS INC
Non-Qualified Stock Option (right to buy)
M - Exercise X -5.000 10.000 -33,33
2021-04-12 2021-04-09 4 CYTK CYTOKINETICS INC
Non-Qualified Stock Option (right to buy)
M - Exercise X -3.207 0 -100,00
2021-04-12 2021-04-09 4 CYTK CYTOKINETICS INC
Common Stock
S - Sale X -4.375 920 -82,63 24,50 -107.188 22.540
2021-04-12 2021-04-09 4 CYTK CYTOKINETICS INC
Common Stock
M - Exercise X 4.375 5.295 475,54 10,00 43.750 52.950
2021-04-12 2021-04-09 4 CYTK CYTOKINETICS INC
Common Stock
S - Sale X -5.000 920 -84,46 23,79 -118.950 21.887
2021-04-12 2021-04-09 4 CYTK CYTOKINETICS INC
Common Stock
M - Exercise X 5.000 5.920 543,48 7,61 38.050 45.051
2021-04-12 2021-04-09 4 CYTK CYTOKINETICS INC
Common Stock
M - Exercise X 5.000 5.920 543,48 7,61 38.050 45.051
2021-04-12 2021-04-09 4 CYTK CYTOKINETICS INC
Common Stock
S - Sale X -5.000 920 -84,46 23,79 -118.942 21.885
2021-04-12 2021-04-09 4 CYTK CYTOKINETICS INC
Common Stock
M - Exercise X 5.000 5.920 543,48 7,61 38.050 45.051
2021-04-12 2021-04-09 4 CYTK CYTOKINETICS INC
Common Stock
S - Sale X -5.000 920 -84,46 23,80 -118.994 21.895
2021-04-12 2021-04-09 4 CYTK CYTOKINETICS INC
Common Stock
M - Exercise X 5.000 5.920 543,48 7,61 38.050 45.051
2021-04-12 2021-04-09 4 CYTK CYTOKINETICS INC
Common Stock
S - Sale X -5.000 920 -84,46 23,79 -118.948 21.886
2021-04-12 2021-04-09 4 CYTK CYTOKINETICS INC
Common Stock
S - Sale X -3.207 920 -77,71 24,00 -76.968 22.080
2021-04-12 2021-04-09 4 CYTK CYTOKINETICS INC
Common Stock
M - Exercise X 3.207 4.127 348,59 6,82 21.872 28.146
2021-04-05 2021-04-01 4 CYTK CYTOKINETICS INC
Common Stock
A - Award 409 920 80,04 24,44 9.996 22.485
2021-01-05 2021-01-04 4 CYTK CYTOKINETICS INC
Common Stock
A - Award 511 511 19,56 9.995 9.995
2020-10-13 2020-10-12 4 AKCA AKCEA THERAPEUTICS, INC.
Stock Option (right to buy)
D - Sale to Issuer -26.400 0 -100,00 2,01 -53.064
2020-10-13 2020-10-12 4 AKCA AKCEA THERAPEUTICS, INC.
Stock Option (right to buy)
D - Sale to Issuer -52.837 0 -100,00 5,94 -313.852
2020-10-05 2020-10-05 4 CYTK CYTOKINETICS INC
Non-Qualified Stock Option (right to buy)
M - Exercise X -5.936 0 -100,00 2,95 -17.511
2020-10-05 2020-10-05 4 CYTK CYTOKINETICS INC
Common Stock
S - Sale X -5.936 0 -100,00 30,00 -178.080
2020-10-05 2020-10-05 4 CYTK CYTOKINETICS INC
Common Stock
M - Exercise X 5.936 5.936 7,37 43.748 43.748
2020-07-17 2020-07-15 4 CYTK CYTOKINETICS INC
Non-Qualified Stock Option (right to buy)
M - Exercise X -6.667 0 -100,00
2020-07-17 2020-07-15 4 CYTK CYTOKINETICS INC
Common Stock
S - Sale X -6.667 0 -100,00 29,00 -193.343
2020-07-17 2020-07-15 4 CYTK CYTOKINETICS INC
Common Stock
M - Exercise X 6.667 6.667 6,21 41.402 41.402
2020-07-13 2020-07-10 4 CYTK CYTOKINETICS INC
Non-Qualified Stock Option (right to buy)
M - Exercise X -6.667 6.667 -50,00
2020-07-13 2020-07-10 4 CYTK CYTOKINETICS INC
Common Stock
S - Sale X -6.667 0 -100,00 28,00 -186.676
2020-07-13 2020-07-10 4 CYTK CYTOKINETICS INC
Common Stock
M - Exercise X 6.667 6.667 6,21 41.402 41.402
2020-07-09 2020-07-08 4 CYTK CYTOKINETICS INC
Non-Qualified Stock Option (right to buy)
M - Exercise X -1.434 13.334 -9,71
2020-07-09 2020-07-08 4 CYTK CYTOKINETICS INC
Common Stock
S - Sale X -1.434 0 -100,00 27,00 -38.718
2020-07-09 2020-07-08 4 CYTK CYTOKINETICS INC
Common Stock
M - Exercise X 1.434 1.434 6,21 8.905 8.905
2020-07-09 2020-07-07 4 CYTK CYTOKINETICS INC
Non-Qualified Stock Option (right to buy)
M - Exercise X -6.510 0 -100,00
2020-07-09 2020-07-07 4 CYTK CYTOKINETICS INC
Non-Qualified Stock Option (right to buy)
M - Exercise X -5.232 14.768 -26,16
2020-07-09 2020-07-07 4 CYTK CYTOKINETICS INC
Common Stock
S - Sale X -6.510 0 -100,00 26,00 -169.260
2020-07-09 2020-07-07 4 CYTK CYTOKINETICS INC
Common Stock
M - Exercise X 6.510 6.510 6,72 43.747 43.747
2020-07-09 2020-07-07 4 CYTK CYTOKINETICS INC
Common Stock
S - Sale X -5.232 0 -100,00 27,00 -141.264
2020-07-09 2020-07-07 4 CYTK CYTOKINETICS INC
Common Stock
M - Exercise X 5.232 5.232 6,21 32.491 32.491
2020-06-22 2020-06-22 4 CYTK CYTOKINETICS INC
Non-Qualified Stock Option (right to buy)
M - Exercise -5.000 0 -100,00
2020-06-22 2020-06-22 4 CYTK CYTOKINETICS INC
Non-Qualified Stock Option (right to buy)
M - Exercise -5.000 0 -100,00
2020-06-22 2020-06-22 4 CYTK CYTOKINETICS INC
Common Stock
S - Sale -5.000 0 -100,00 24,00 -120.000
2020-06-22 2020-06-22 4 CYTK CYTOKINETICS INC
Common Stock
M - Exercise 5.000 5.000 4,44 22.200 22.200
2020-06-22 2020-06-22 4 CYTK CYTOKINETICS INC
Common Stock
M - Exercise 5.000 5.000 4,44 22.200 22.200
2020-06-22 2020-06-22 4 CYTK CYTOKINETICS INC
Common Stock
S - Sale -5.000 0 -100,00 25,00 -125.000
2020-06-17 2020-06-17 4 CYTK CYTOKINETICS INC
Non-Qualified Stock Option (right to buy)
M - Exercise -2.741 0 -100,00
2020-06-17 2020-06-17 4 CYTK CYTOKINETICS INC
Non-Qualified Stock Option (right to buy)
M - Exercise -4.166 0 -100,00
2020-06-17 2020-06-17 4 CYTK CYTOKINETICS INC
Common Stock
S - Sale -2.741 0 -100,00 23,00 -63.043
2020-06-17 2020-06-17 4 CYTK CYTOKINETICS INC
Common Stock
M - Exercise 2.741 2.741 6,84 18.748 18.748
2020-06-17 2020-06-17 4 CYTK CYTOKINETICS INC
Common Stock
S - Sale -4.166 0 -100,00 23,00 -95.818
2020-06-17 2020-06-17 4 CYTK CYTOKINETICS INC
Common Stock
M - Exercise 4.166 4.166 6,78 28.245 28.245
2020-06-15 2020-06-15 4 CYTK CYTOKINETICS INC
Non-Qualified Stock Option (right to buy)
M - Exercise -6.666 0 -100,00
2020-06-15 2020-06-15 4 CYTK CYTOKINETICS INC
Common Stock
S - Sale -6.666 0 -100,00 22,00 -146.652
2020-06-15 2020-06-15 4 CYTK CYTOKINETICS INC
Common Stock
M - Exercise 6.666 6.666 6,30 41.996 41.996
2020-06-12 2020-06-12 4 CYTK CYTOKINETICS INC
Non-Qualified Stock Option (right to buy)
M - Exercise -4.166 0 -100,00
2020-06-12 2020-06-12 4 CYTK CYTOKINETICS INC
Non-Qualified Stock Option (right to buy)
M - Exercise -10.879 0 -100,00
2020-06-12 2020-06-12 4 CYTK CYTOKINETICS INC
Common Stock
S - Sale -4.166 0 -100,00 21,10 -87.903
2020-06-12 2020-06-12 4 CYTK CYTOKINETICS INC
Common Stock
M - Exercise 4.166 4.166 5,46 22.746 22.746
2020-06-12 2020-06-12 4 CYTK CYTOKINETICS INC
Common Stock
S - Sale -10.879 0 -100,00 20,77 -226.005
2020-06-12 2020-06-12 4 CYTK CYTOKINETICS INC
Common Stock
M - Exercise 10.879 10.879 4,02 43.734 43.734
2020-05-14 2020-05-13 4 CYTK CYTOKINETICS INC
Non-Qualified Stock Option (right to buy)
A - Award 20.000 20.000 21,61 432.200 432.200
2020-04-15 2020-04-13 4 AKCA AKCEA THERAPEUTICS, INC.
Stock Option (right to buy)
A - Award 26.400 26.400
2020-02-14 2020-02-12 4 CYTK CYTOKINETICS INC
Non-Qualified Stock Option (right to buy)
A - Award 4.124 4.124 15,43 63.633 63.633
2020-01-29 2020-01-02 4/A CYTK CYTOKINETICS INC
Non-Qualified Stock Option (right to buy)
A - Award 4.739 4.739 10,55 49.996 49.996
2020-01-06 2020-01-02 4 CYTK CYTOKINETICS INC
Non-Qualified Stock Option (right to buy)
A - Award 758 758 10,55 7.997 7.997
2019-07-03 2019-07-01 4 CUR Neuralstem, Inc.
Common Stock
A - Award 166.667 219.916 313,00
2019-06-18 2019-06-14 4 AKCA AKCEA THERAPEUTICS, INC.
Stock Option (right to buy)
A - Award 26.400 26.400
2019-05-17 2019-05-15 4 CYTK CYTOKINETICS INC
Non-Qualified Stock Option (right to buy)
A - Award 20.000 20.000 10,68 213.600 213.600
2019-01-04 2019-01-02 4 CYTK CYTOKINETICS INC
Non-Qualified Stock Option (right to buy)
A - Award 3.207 3.207 6,82 21.872 21.872
2018-07-05 2018-07-02 4 CUR Neuralstem, Inc.
Common Stock
A - Award 45.046 50.899 769,62
2018-06-05 2018-06-01 4 AKCA AKCEA THERAPEUTICS, INC.
Stock Option (right to buy)
A - Award 26.400 26.400
2018-05-17 2018-05-16 4 CYTK CYTOKINETICS INC
Non-Qualified Stock Option (right to buy)
A - Award 20.000 20.000 9,45 189.000 189.000
2018-01-08 2018-01-04 4 APRI APRICUS BIOSCIENCES, INC.
Stock Option (right to buy)
A - Award 35.000 35.000
2018-01-04 2018-01-02 4 CYTK CYTOKINETICS INC
Non-Qualified Stock Option (right to buy)
A - Award 5.714 5.714 3,50 20.000 20.000
2017-07-18 2017-07-14 4 CUR Neuralstem, Inc.
Restricted Stock Units
A - Award 9.311 9.311
2017-05-22 2017-05-18 4 CYTK CYTOKINETICS INC
Non-Qualified Stock Option (right to buy)
A - Award 20.000 20.000
2017-02-03 2017-01-27 4/A NVLN NOVELION THERAPEUTICS INC.
Common Shares
M - Exercise 456 1.048 77,03
2017-01-31 2017-01-27 4 NVLN NOVELION THERAPEUTICS INC.
Restricted Stock Units
M - Exercise -456 1.367 -25,01
2017-01-31 2017-01-27 4 NVLN NOVELION THERAPEUTICS INC.
Common Shares
F - Taxes -148 900 -14,12 9,38 -1.388 8.442
2017-01-31 2017-01-27 4 NVLN NOVELION THERAPEUTICS INC.
Common Shares
M - Exercise 456 1.048 77,03
2017-01-06 2017-01-05 4 APRI APRICUS BIOSCIENCES, INC.
Common Stock
A - Award 11.250 16.160 229,12
2017-01-04 2017-01-03 4 CYTK CYTOKINETICS INC
Non-Qualified Stock Option (right to buy)
A - Award 4.032 4.032 4,96 20.000 20.000
2016-12-27 2016-12-22 4 NVLN NOVELION THERAPEUTICS INC.
Stock Option (Right to Buy)
A - Award 9.600 9.600
2016-12-01 2016-11-29 4 NVLN QLT INC/BC
Restricted Stock Units
A - Award 9.115 9.115
2016-12-01 2016-11-29 4 NVLN QLT INC/BC
Common Shares, without par value
A - Award 2.963 2.963
2016-11-30 2016-11-29 4 AEGR Aegerion Pharmaceuticals, Inc.
Restricted Stock Units
D - Sale to Issuer -8.888 0 -100,00
2016-11-30 2016-11-29 4 AEGR Aegerion Pharmaceuticals, Inc.
Stock Option (Right to Buy)
D - Sale to Issuer -40.000 0 -100,00
2016-11-30 2016-11-29 4 AEGR Aegerion Pharmaceuticals, Inc.
Stock Option (Right to Buy)
D - Sale to Issuer -18.000 0 -100,00
2016-11-30 2016-11-29 4 AEGR Aegerion Pharmaceuticals, Inc.
Stock Option (Right to Buy)
D - Sale to Issuer -5.012 0 -100,00
2016-11-30 2016-11-29 4 AEGR Aegerion Pharmaceuticals, Inc.
Stock Option (Right to Buy)
D - Sale to Issuer -14.700 0 -100,00
2016-11-30 2016-11-29 4 AEGR Aegerion Pharmaceuticals, Inc.
Stock Option (Right to Buy)
D - Sale to Issuer -8.569 0 -100,00
2016-11-30 2016-11-29 4 AEGR Aegerion Pharmaceuticals, Inc.
Stock Option (Right to Buy)
D - Sale to Issuer -16.435 0 -100,00
2016-11-30 2016-11-29 4 AEGR Aegerion Pharmaceuticals, Inc.
Common Stock
D - Sale to Issuer -2.890 0 -100,00
2016-10-03 2016-09-30 4 APRI APRICUS BIOSCIENCES, INC.
Common Stock
A - Award 9.607 49.093 24,33 0,34 3.250 16.608
2016-07-29 2016-07-27 4 AEGR Aegerion Pharmaceuticals, Inc.
Restricted Stock Units
M - Exercise -2.222 8.888 -20,00
2016-07-29 2016-07-27 4 AEGR Aegerion Pharmaceuticals, Inc.
Common Stock
F - Taxes -777 2.890 -21,19 1,55 -1.204 4.480
2016-07-29 2016-07-27 4 AEGR Aegerion Pharmaceuticals, Inc.
Common Stock
M - Exercise 2.222 3.667 153,77
2016-07-01 2016-06-30 4 APRI APRICUS BIOSCIENCES, INC.
Common Stock
A - Award 8.136 39.486 25,95 0,40 3.250 15.775
2016-05-20 2016-05-18 4 CYTK CYTOKINETICS INC
Non-Qualified Stock Option (right to buy)
A - Award 20.000 20.000
2016-04-07 2016-04-05 4 APRI APRICUS BIOSCIENCES, INC.
Common Stock
A - Award 4.850 31.350 18,30 0,58 2.813 18.183
2016-01-29 2016-01-27 4 AEGR Aegerion Pharmaceuticals, Inc.
Restricted Stock Units
M - Exercise -2.223 11.110 -16,67
2016-01-29 2016-01-27 4 AEGR Aegerion Pharmaceuticals, Inc.
Common Stock
F - Taxes -778 1.445 -35,00 6,78 -5.275 9.797
2016-01-29 2016-01-27 4 AEGR Aegerion Pharmaceuticals, Inc.
Common Stock
M - Exercise 2.223 2.223
2016-01-06 2016-01-04 4 CYTK CYTOKINETICS INC
Non-Qualified Stock Option (right to buy)
A - Award 4.375 4.375 4,00 17.500 17.500
2016-01-05 2016-01-04 4 APRI APRICUS BIOSCIENCES, INC.
Stock Option (right to buy)
A - Award 25.000 25.000
2015-08-25 2015-08-21 4 AEGR Aegerion Pharmaceuticals, Inc.
Restricted Stock Units
A - Award 13.333 13.333
2015-08-25 2015-08-21 4 AEGR Aegerion Pharmaceuticals, Inc.
Stock Option (right to buy)
A - Award 40.000 40.000
2015-07-06 2015-07-01 4 CUR Neuralstem, Inc.
Common Stock
A - Award 106.952 106.952
2015-06-29 2015-06-26 4 AEGR Aegerion Pharmaceuticals, Inc.
Stock Option (right to buy)
A - Award 18.000 18.000
2015-05-21 2015-05-20 4 CYTK CYTOKINETICS INC
Stock Option (right to buy)
A - Award 20.000 20.000
2015-01-26 2015-01-02 4 APRI APRICUS BIOSCIENCES, INC.
Stock Option (right to buy)
A - Award 25.000 25.000
2015-01-05 2015-01-02 4 CYTK CYTOKINETICS INC
Non-Qualified Stock Option (right to buy)
A - Award 5.936 5.936 2,95 17.511 17.511
2014-10-24 2014-10-23 4 APRI APRICUS BIOSCIENCES, INC.
Common Stock
P - Purchase 18.200 26.500 219,28 1,59 28.998 42.222
2014-10-24 2014-10-22 4 APRI APRICUS BIOSCIENCES, INC.
Common Stock
P - Purchase 8.300 8.300 1,52 12.651 12.651
2014-08-12 2014-08-08 4 APRI APRICUS BIOSCIENCES, INC.
Stock Option (right to buy)
A - Award 85.000 85.000
2014-08-07 2014-08-01 4 CUR Neuralstem, Inc.
Common Stock purchase option
A - Award 74.367 74.367
2014-07-31 3 CUR Neuralstem, Inc.
Common Stock
50.000
2014-07-31 3 CUR Neuralstem, Inc.
Common Stock
50.000
2014-06-30 2014-06-26 4 AEGR Aegerion Pharmaceuticals, Inc.
Stock Option (right to buy)
A - Award 5.012 5.012
2014-05-22 2014-05-21 4 CYTK CYTOKINETICS INC
Non-Qualified Stock Option (right to buy)
A - Award 10.000 10.000
2014-01-03 2014-01-02 4 CYTK CYTOKINETICS INC
Non-Qualified Stock Option (right to buy)
A - Award 6.510 6.510 2,69 17.512 17.512
2013-10-31 2013-10-29 4 AEGR Aegerion Pharmaceuticals, Inc.
Stock Option (right to buy)
M - Exercise -2.502 8.569 -22,60
2013-10-31 2013-10-29 4 AEGR Aegerion Pharmaceuticals, Inc.
Common Stock
S - Sale X -2.502 0 -100,00 95,00 -237.690
2013-10-31 2013-10-29 4 AEGR Aegerion Pharmaceuticals, Inc.
Common Stock
M - Exercise 2.502 2.502 15,00 37.530 37.530
2013-08-13 2013-08-12 4 AEGR Aegerion Pharmaceuticals, Inc.
Common Stock
S - Sale -1.537 0 -100,00 92,25 -141.791
2013-08-13 2013-08-09 4 AEGR Aegerion Pharmaceuticals, Inc.
Stock Option (right to buy)
M - Exercise -1.783 11.071 -13,87
2013-08-13 2013-08-09 4 AEGR Aegerion Pharmaceuticals, Inc.
Stock Option (right to buy)
M - Exercise -8.217 16.435 -33,33
2013-08-13 2013-08-09 4 AEGR Aegerion Pharmaceuticals, Inc.
Common Stock
S - Sale -8.463 1.537 -84,63 92,33 -781.414 141.916
2013-08-13 2013-08-09 4 AEGR Aegerion Pharmaceuticals, Inc.
Common Stock
M - Exercise 1.783 10.000 21,70 15,00 26.745 150.000
2013-08-13 2013-08-09 4 AEGR Aegerion Pharmaceuticals, Inc.
Common Stock
M - Exercise 8.217 8.217 16,28 133.773 133.773
2013-06-28 2013-06-26 4 AEGR Aegerion Pharmaceuticals, Inc.
Stock Option (right to buy)
A - Award 14.700 14.700
2013-05-29 2013-05-22 4 CYTK CYTOKINETICS INC
Non-Qualified Stock Option (right to buy)
A - Award 25.000 25.000
2013-01-04 2013-01-02 4 CYTK CYTOKINETICS INC
Non-Qualified Stock Option (right to buy)
A - Award 65.279 65.279 0,27 17.501 17.501
2012-06-07 2012-06-05 4 AEGR Aegerion Pharmaceuticals, Inc.
Stock Option (right to buy)
A - Award 12.854 12.854
2012-05-24 2012-05-22 4 CYTK CYTOKINETICS INC
Non-Qualified Stock Option (right to buy)
A - Award 25.000 25.000
2012-04-04 2012-04-02 4 CYTK CYTOKINETICS INC
Non-Qualified Stock Option (right to buy)
A - Award 16.447 16.447 0,46 7.500 7.500
2012-03-07 2012-03-05 4 CYTK CYTOKINETICS INC
Non-Qualified Stock Option (right to buy)
A - Award 40.000 40.000
2012-01-05 2012-01-03 4 AEGR Aegerion Pharmaceuticals, Inc.
Stock Option (right to buy)
A - Award 24.652 24.652
P
Åbent marked eller privat køb af ikke-afledte eller afledte værdipapirer
S
Åbent marked eller privat salg af ikke-afledte eller afledte værdipapirer
A
Tildeling, tildeling eller anden erhvervelse af værdipapirer fra virksomheden (såsom en option)
C
Konvertering af derivat
D
Salg eller overførsel af værdipapirer tilbage til virksomheden
F
Betaling af udnyttelseskurs eller skatteforpligtelse ved brug af en del af værdipapirer modtaget fra selskabet
G
Gave af værdipapirer af eller til insideren
K
Aktieswaps og lignende sikringstransaktioner
M
Udnyttelse eller konvertering af afledt værdipapir modtaget fra virksomheden (såsom en option)
V
En transaktion rapporteret frivilligt på formular 4
J
Andet (ledsaget af en fodnote, der beskriver transaktionen)